The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma

Background: N6-methyladenosine (m6A), 5-methylcytosine (m5C) and N1-methyladenosine (m1A) are the main RNA methylation modifications involved in the progression of cancer. However, it is still unclear whether m6A/m5C/m1A-related long non-coding RNAs (lncRNAs) affect the prognosis of head and neck sq...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Enhao Wang, Yang Li, Ruijie Ming, Jiahui Wei, Peiyu Du, Peng Zhou, Shimin Zong, Hongjun Xiao
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/0e7ea520e6c049719a35e0d12d2352a9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0e7ea520e6c049719a35e0d12d2352a9
record_format dspace
spelling oai:doaj.org-article:0e7ea520e6c049719a35e0d12d2352a92021-12-01T19:25:55ZThe Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma2296-634X10.3389/fcell.2021.718974https://doaj.org/article/0e7ea520e6c049719a35e0d12d2352a92021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.718974/fullhttps://doaj.org/toc/2296-634XBackground: N6-methyladenosine (m6A), 5-methylcytosine (m5C) and N1-methyladenosine (m1A) are the main RNA methylation modifications involved in the progression of cancer. However, it is still unclear whether m6A/m5C/m1A-related long non-coding RNAs (lncRNAs) affect the prognosis of head and neck squamous cell carcinoma (HNSCC).Methods: We summarized 52 m6A/m5C/m1A-related genes, downloaded 44 normal samples and 501 HNSCC tumor samples with RNA-seq data and clinical information from The Cancer Genome Atlas (TCGA) database, and then searched for m6A/m5C/m1A-related genes co-expressed lncRNAs. We adopt the least absolute shrinkage and selection operator (LASSO) Cox regression to obtain m6A/m5C/m1A-related lncRNAs to construct a prognostic signature of HNSCC.Results: This prognostic signature is based on six m6A/m5C/m1A-related lncRNAs (AL035587.1, AC009121.3, AF131215.5, FMR1-IT1, AC106820.5, PTOV1-AS2). It was found that the high-risk subgroup has worse overall survival (OS) than the low-risk subgroup. Moreover, the results showed that most immune checkpoint genes were significantly different between the two risk groups (p < 0.05). Immunity microenvironment analysis showed that the contents of NK cell resting, macrophages M2, and neutrophils in samples of low-risk group were significantly lower than those of high-risk group (p < 0.05), while the contents of B cells navie, plasma cells, and T cells regulatory (Tregs) were on the contrary (p < 0.05). In addition, patients with high tumor mutational burden (TMB) had the worse overall survival than those with low tumor mutational burden.Conclusion: Our study elucidated how m6A/m5C/m1A-related lncRNAs are related to the prognosis, immune microenvironment, and TMB of HNSCC. In the future, these m6A/m5C/m1A-related lncRNAs may become a new choice for immunotherapy of HNSCC.Enhao WangYang LiRuijie MingJiahui WeiPeiyu DuPeng ZhouShimin ZongHongjun XiaoFrontiers Media S.A.articleRNA methylationlong non-coding RNAprognostic signaturehead and neck squamous cell carcinomaepigenetic changeBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic RNA methylation
long non-coding RNA
prognostic signature
head and neck squamous cell carcinoma
epigenetic change
Biology (General)
QH301-705.5
spellingShingle RNA methylation
long non-coding RNA
prognostic signature
head and neck squamous cell carcinoma
epigenetic change
Biology (General)
QH301-705.5
Enhao Wang
Yang Li
Ruijie Ming
Jiahui Wei
Peiyu Du
Peng Zhou
Shimin Zong
Hongjun Xiao
The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
description Background: N6-methyladenosine (m6A), 5-methylcytosine (m5C) and N1-methyladenosine (m1A) are the main RNA methylation modifications involved in the progression of cancer. However, it is still unclear whether m6A/m5C/m1A-related long non-coding RNAs (lncRNAs) affect the prognosis of head and neck squamous cell carcinoma (HNSCC).Methods: We summarized 52 m6A/m5C/m1A-related genes, downloaded 44 normal samples and 501 HNSCC tumor samples with RNA-seq data and clinical information from The Cancer Genome Atlas (TCGA) database, and then searched for m6A/m5C/m1A-related genes co-expressed lncRNAs. We adopt the least absolute shrinkage and selection operator (LASSO) Cox regression to obtain m6A/m5C/m1A-related lncRNAs to construct a prognostic signature of HNSCC.Results: This prognostic signature is based on six m6A/m5C/m1A-related lncRNAs (AL035587.1, AC009121.3, AF131215.5, FMR1-IT1, AC106820.5, PTOV1-AS2). It was found that the high-risk subgroup has worse overall survival (OS) than the low-risk subgroup. Moreover, the results showed that most immune checkpoint genes were significantly different between the two risk groups (p < 0.05). Immunity microenvironment analysis showed that the contents of NK cell resting, macrophages M2, and neutrophils in samples of low-risk group were significantly lower than those of high-risk group (p < 0.05), while the contents of B cells navie, plasma cells, and T cells regulatory (Tregs) were on the contrary (p < 0.05). In addition, patients with high tumor mutational burden (TMB) had the worse overall survival than those with low tumor mutational burden.Conclusion: Our study elucidated how m6A/m5C/m1A-related lncRNAs are related to the prognosis, immune microenvironment, and TMB of HNSCC. In the future, these m6A/m5C/m1A-related lncRNAs may become a new choice for immunotherapy of HNSCC.
format article
author Enhao Wang
Yang Li
Ruijie Ming
Jiahui Wei
Peiyu Du
Peng Zhou
Shimin Zong
Hongjun Xiao
author_facet Enhao Wang
Yang Li
Ruijie Ming
Jiahui Wei
Peiyu Du
Peng Zhou
Shimin Zong
Hongjun Xiao
author_sort Enhao Wang
title The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
title_short The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
title_full The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
title_fullStr The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
title_full_unstemmed The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
title_sort prognostic value and immune landscapes of a m6a/m5c/m1a-related lncrnas signature in head and neck squamous cell carcinoma
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/0e7ea520e6c049719a35e0d12d2352a9
work_keys_str_mv AT enhaowang theprognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT yangli theprognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT ruijieming theprognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT jiahuiwei theprognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT peiyudu theprognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT pengzhou theprognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT shiminzong theprognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT hongjunxiao theprognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT enhaowang prognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT yangli prognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT ruijieming prognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT jiahuiwei prognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT peiyudu prognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT pengzhou prognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT shiminzong prognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
AT hongjunxiao prognosticvalueandimmunelandscapesofam6am5cm1arelatedlncrnassignatureinheadandnecksquamouscellcarcinoma
_version_ 1718404616230535168